Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    How I’d invest £20,000 in a Stocks and Shares ISA to target lifelong passive income

    | Stephen Wright

    What should investors look for when investing in a Stocks and Shares ISA? Stephen Wright thinks the key for passive…

    Read more »

    Investor looking at stock graph on a tablet with their finger hovering over the Buy button
    Investing Articles

    Down more than 10% in 2023, Fools are backing these 5 UK stocks to reverse that – and then some! – in 2024

    | The Motley Fool Staff

    Five Fools see buying opportunities among these beaten-down shares in the UK stock markets!

    Read more »

    The Mall in Westminster, leading to Buckingham Palace
    Investing Articles

    If I had to buy just one FTSE 100 stock in 2024, it would be this

    | Ben McPoland

    This Fool considered which FTSE 100 (INDEXFTSE:UKX) stock he’d buy next year if given only one choice. Here’s the champ…

    Read more »

    Concept of two young professional men looking at a screen in a technological data centre
    Investing Articles

    Are these 2 FTSE 100 companies recession-resistant?

    | Zaven Boyrazian, MSc

    Zaven Boyrazian explores two FTSE 100 giants that could outperform the stock market in the event of a near-term recession…

    Read more »

    Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
    Investing Articles

    Here’s a FTSE 100 giant I’m eyeing up for December!

    | Sumayya Mansoor

    This Fool explains why this FTSE 100 pharma giant is on her radar. She plans to snap up shares for…

    Read more »

    Playful senior couple in aprons dancing and smiling while preparing healthy dinner at home
    Investing Articles

    Here’s 1 thriving FTSE 100 stock I’d snap up in November

    | Zaven Boyrazian, MSc

    Stock market volatility has created some exciting opportunities within FTSE 100 stocks. But is this business currently the best bargain?

    Read more »

    Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
    Value Shares

    UK shares near 52-week lows: 2 I like and 1 I’d avoid

    | Edward Sheldon, CFA

    Edward Sheldon has been scanning the FTSE 350 index for shares trading near their 52-week lows and has identified a…

    Read more »

    Engineer Project Manager Talks With Scientist working on Computer
    Investing Articles

    Does the AstraZeneca share price scream value?

    | Dr. James Fox

    Dr James Fox takes a closer look at the AstraZeneca share price following the company's Q3 results. Is this growth-focused…

    Read more »

    Smart young brown businesswoman working from home on a laptop
    Investing Articles

    After a rocky October, are AstraZeneca shares now a buy?

    | Gordon

    AstraZeneca shares fell sharply in October following disappointing results in a clinical trial. Are they now primed for a bounce?

    Read more »

    Businesswoman calculating finances in an office
    Investing Articles

    What’s going on with the AstraZeneca share price?

    | Mark Tovey

    The AstraZeneca share price took a nasty nosedive last week. That came after bad news about a lung cancer drug…

    Read more »

    Investing Articles

    Will litigation news help to move the AstraZeneca share price?

    | Kevin Godbold

    Can the removal of uncertainty over litigation issues get the AstraZeneca share price moving higher in the coming weeks?

    Read more »

    Middle-aged Caucasian woman deep in thought while looking out of the window
    Investing Articles

    Which is the best value stock now: AstraZeneca or GSK?

    | Kevin Godbold

    There’s value in the pharmaceutical sector, but these two FTSE 100 stocks have quite different characteristics to consider.

    Read more »